PerkinElmer Q2 Profit Declines 15 Percent on 2.5-Percent Revenue Growth | GenomeWeb

PerkinElmer Q2 Profit Declines 15 Percent on 2.5-Percent Revenue Growth

Jul 28, 2006

This article has been updated to correct the change in PerkinElmer's net income, which declined to $24.5 million, not by $24.5 million.

NEW YORK (GenomeWeb News) – PerkinElmer today said second-quarter net income declined 15 percent as revenues inched up 2.5 percent.

Receipts for the three months ended July 2 increased to $377 million from $368 million year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Spiders and Scorpions, Oh My!

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

Keep It Secret

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Page Joins Chronic Disease Startup

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

This Week in Cell

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.